Cutting Edge introduction: another FVA?

Including funding costs and benefits in derivatives prices is a controversial topic, closely tied up with the credit and debit valuation adjustments of counterparty risk. But new research suggests that, even with no default risk, differences in the levels at which a party can lend and borrow affect buy and sell prices, with complex effects on valuation. Laurie Carver introduces this month’s technical articles


Over the past few years, quants have been fighting about whether to include funding costs in derivatives prices, through a funding valuation adjustment (FVA) closely related to counterparty risk. For many, a starting point was an article published in the February 2010 issue of Risk, Funding beyond discounting: collateral agreements and derivatives pricing (Risk February 2010, pages 98–102) by Vladimir Piterbarg, global head of quantitative finance at Barclays in London. That article showed that

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here